SCHEMBL28972010

SCHEMBL28972010

Nc1[c]sc(Nc2ccccc2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 1/20 0.51
PLK3 Q9H4B4 1/20 0.51
RAB9A P51151 8/20 0.43
MAPT P10636 8/20 0.43
NPC1 O15118 6/20 0.43
KMT2A Q03164 6/20 0.43
GAA P10253 6/20 0.43
MEN1 O00255 5/20 0.43
ALDH1A1 P00352 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
CASP3 P42574 2/20 0.43
SENP8 Q96LD8 2/20 0.43
SENP7 Q9BQF6 2/20 0.43
SENP6 Q9GZR1 2/20 0.43
CDK5 Q00535 2/20 0.43
CDK5R1 Q15078 2/20 0.43
LMNA P02545 2/20 0.43
TP53 P04637 2/20 0.43
HPGD P15428 1/20 0.43
TDP1 Q9NUW8 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4100236 0.72 RAB9A (0.61) CSNK2A1PLK3RAB9AMAPTNPC1
SCHEMBL27199981 0.68 CSNK2A1 (1.00) CSNK2A1PLK3RAB9AMAPTNPC1
SCHEMBL8625316 0.65 HSD17B10 (0.42) CSNK2A1PLK3RAB9AMAPTNPC1
SCHEMBL5157724 0.65 SCN9A (0.57) CSNK2A1PLK3RAB9AMAPTNPC1
Diphenylamine SCHEMBL9840889 0.65 HSD17B10 (0.80) RAB9AMAPTKMT2AGAAMEN1
SCHEMBL11666704 0.65 RAB9A (0.59) CSNK2A1PLK3RAB9AMAPTNPC1
SCHEMBL11578760 0.64 MAPT (0.52) CSNK2A1PLK3RAB9AMAPTKMT2A
Diphenylamine SCHEMBL23722810 0.63 HSD17B10 (0.57) CSNK2A1PLK3RAB9AMAPTNPC1
Hydrochloric Acid SCHEMBL11579145 0.63 MAPT (0.50) CSNK2A1PLK3RAB9AMAPTNPC1
Hydrochloric Acid SCHEMBL11580554 0.63 MAPT (0.50) CSNK2A1PLK3RAB9AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115697980-A Substituted aminothiazoles as DGKZETA inhibitors for immune activation 拜耳公司 2023-02-03 CN disclosed